Get the Stockscreener App
54.24
2.65%
1.40
Moonlake Immunotherapeutics Stock (MLTX) Forecast
The Moonlake Immunotherapeutics (MLTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $110.80, representing a +104.27% increase from the current price of $54.24. The highest analyst price target is $114.97, and the lowest is $106.63.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MLTX Price Target
Average 186.34
(+243.55% Upside)
Is Moonlake Immunotherapeutics (MLTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 60.21 | Neutral |
| STOCH(9,6) | 68.82 | Neutral |
| STOCHRSI(14) | 72.49 | Neutral |
| MACD(12,26) | 1.1453 | Buy |
| ADX(14) | 18.25 | Neutral |
| William %R | -18.51 | Sell |
| CCI(14) | 86.71 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
51.65
Buy
|
52.26
Buy
|
| MA20 |
50.72
Buy
|
51.21
Buy
|
| MA50 |
50.25
Buy
|
49.93
Buy
|
| MA100 |
48.38
Buy
|
48.76
Buy
|
| MA200 |
46.68
Buy
|
48.78
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, MLTX could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 1 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on MLTX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 60.21 indicates that MLTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 68.82 indicates that MLTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 72.49 indicates that MLTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.25 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 86.71 indicates that MLTX is still overbought but not to an extreme extent.
Long-term MLTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Moonlake Immunotherapeutics financial reports and earnings history, Moonlake Immunotherapeutics (MLTX) stock could reach $567.45 by 2030, $1,971.43 by 2040 and $1,827.33 by 2050. See the projected annual prices until 2050 of the Moonlake Immunotherapeutics stock below:
- Moonlake Immunotherapeutics (MLTX) is expected to reach an average price of $1,185.88 in 2035, with a high prediction of $1,188.85 and a low estimate of $1,124.93. This indicates an $2,086% rise from the last recorded price of $54.24.
- Moonlake Immunotherapeutics (MLTX) stock is projected to chart a bullish course in 2040, with an average price target of $319.69, representing an $489.41% surge from its current level. The forecast ranges from a conservative $302.36 to a sky-high $1,971.43.
- Our analysts predict Moonlake Immunotherapeutics (MLTX) to jump 1,661% by 2045, soaring from $892.40 to an average price of $955.23, potentially reaching $955.56. While $892.40 is the low estimate, the potential upside is significant.
- Moonlake Immunotherapeutics (MLTX) stock is expected to climb by 2050, reaching an average of $1,822.39, a $3,260% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,827.33 and $1,745.65, respectively, highlighting the market's uncertainty.
Moonlake Immunotherapeutics Stock (MLTX) Year by Year Forecast
Moonlake Immunotherapeutics Stock (MLTX) Price Forecast for 2024
Our forecast for MLTX stock price in 2024 now indicates an average price target of $77.71 with a high forecast of $114.97 and a low forecast of $40.45. The average prediction reflects an increase of +43.27% from the last recorded price of $54.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $114.51 | $106.63 | $114.97 | +111.11% |
Moonlake Immunotherapeutics Stock (MLTX) Price Forecast for 2025
Moonlake Immunotherapeutics Stock (MLTX) is expected to reach an average price of $193.45 in 2025, with a high prediction of $270.86 and a low estimate of $116.03. This indicates an +256.65% rise from the last recorded price of $54.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $127.06 | $116.03 | $128.16 | +134.25% |
| February, 2025 | $135.44 | $128.17 | $135.85 | +149.70% |
| March, 2025 | $150.79 | $137.38 | $151.52 | +178.01% |
| April, 2025 | $163.26 | $153.17 | $165.31 | +201.00% |
| May, 2025 | $171.39 | $162.44 | $176.33 | +215.99% |
| June, 2025 | $185.63 | $172.49 | $188.61 | +242.23% |
| July, 2025 | $194.46 | $187.26 | $197.50 | +258.51% |
| August, 2025 | $233.44 | $209.69 | $237.06 | +330.37% |
| September, 2025 | $241.15 | $231.36 | $244.33 | +344.60% |
| October, 2025 | $246.42 | $241.83 | $249.73 | +354.32% |
| November, 2025 | $263.92 | $248.14 | $266.06 | +386.58% |
| December, 2025 | $265.05 | $255.63 | $270.86 | +388.66% |
Moonlake Immunotherapeutics Stock (MLTX) Price Forecast for 2026
The predicted value for Moonlake Immunotherapeutics (MLTX) in 2026 is set at an average of $199.37. Estimates vary from a peak of $319.05 to a trough of $79.70, indicating an +267.58% surge from the present price of $54.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $265.90 | $250.93 | $268.96 | +390.22% |
| February, 2026 | $290.35 | $267.40 | $291.52 | +435.31% |
| March, 2026 | $291.95 | $288.53 | $297.23 | +438.26% |
| April, 2026 | $308.61 | $293.23 | $313.67 | +468.97% |
| May, 2026 | $302.52 | $299.88 | $310.35 | +457.74% |
| June, 2026 | $312.30 | $301.39 | $317.06 | +475.77% |
| July, 2026 | $314.48 | $309.91 | $319.05 | +479.79% |
| August, 2026 | $94.71 | $79.70 | $95.09 | +74.60% |
| September, 2026 | $112.96 | $95.50 | $113.04 | +108.25% |
| October, 2026 | $128.90 | $116.33 | $131.31 | +137.65% |
| November, 2026 | $148.01 | $132.85 | $149.12 | +172.89% |
| December, 2026 | $168.26 | $152.12 | $168.52 | +210.21% |
Moonlake Immunotherapeutics Stock (MLTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Moonlake Immunotherapeutics (MLTX) is $302.43, with a high forecast of $433.00 and a low forecast of $171.85. This indicates an +457.57% increase from the last price of $54.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $184.91 | $171.85 | $185.32 | +240.91% |
| February, 2027 | $201.84 | $188.80 | $203.30 | +272.13% |
| March, 2027 | $223.02 | $205.36 | $223.63 | +311.16% |
| April, 2027 | $242.23 | $227.09 | $243.33 | +346.59% |
| May, 2027 | $258.82 | $245.40 | $259.23 | +377.18% |
| June, 2027 | $289.32 | $262.82 | $290.12 | +433.41% |
| July, 2027 | $305.14 | $291.19 | $307.19 | +462.57% |
| August, 2027 | $321.48 | $306.37 | $326.42 | +492.70% |
| September, 2027 | $347.93 | $324.64 | $349.32 | +541.47% |
| October, 2027 | $363.04 | $351.14 | $366.08 | +569.32% |
| November, 2027 | $410.23 | $380.33 | $413.85 | +656.32% |
| December, 2027 | $431.76 | $410.21 | $433.00 | +696.02% |
Moonlake Immunotherapeutics Stock (MLTX) Price Forecast for 2028
In 2028, Moonlake Immunotherapeutics (MLTX) is projected to reach an average price of $355.63, with a high projection of $594.44 and a low estimate of $116.81. This indicates an +555.65% rise from the last price of $54.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $441.71 | $433.26 | $445.02 | +714.35% |
| February, 2028 | $467.42 | $445.47 | $469.56 | +761.76% |
| March, 2028 | $478.82 | $461.19 | $481.12 | +782.78% |
| April, 2028 | $487.88 | $466.76 | $490.94 | +799.49% |
| May, 2028 | $524.91 | $491.44 | $528.29 | +867.75% |
| June, 2028 | $538.13 | $522.85 | $539.32 | +892.13% |
| July, 2028 | $557.30 | $540.44 | $562.36 | +927.48% |
| August, 2028 | $565.18 | $552.68 | $567.23 | +941.99% |
| September, 2028 | $578.27 | $569.28 | $582.08 | +966.13% |
| October, 2028 | $586.80 | $579.15 | $594.44 | +981.85% |
| November, 2028 | $141.15 | $116.81 | $144.91 | +160.23% |
| December, 2028 | $166.50 | $146.62 | $166.58 | +206.97% |
Moonlake Immunotherapeutics Stock (MLTX) Price Forecast for 2029
The 2029 price forecast for Moonlake Immunotherapeutics Stock (MLTX) is $340.80 on average, with a high prediction of $509.68 and a low estimate of $171.92. This represents an +528.33% increase from the previous price of $54.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $197.41 | $171.92 | $197.41 | +263.96% |
| February, 2029 | $224.70 | $203.84 | $224.85 | +314.28% |
| March, 2029 | $248.50 | $229.44 | $248.77 | +358.16% |
| April, 2029 | $273.37 | $254.16 | $273.78 | +404.01% |
| May, 2029 | $305.39 | $279.32 | $305.41 | +463.03% |
| June, 2029 | $329.97 | $311.01 | $330.58 | +508.35% |
| July, 2029 | $357.40 | $336.10 | $358.50 | +558.92% |
| August, 2029 | $391.10 | $362.62 | $392.32 | +621.06% |
| September, 2029 | $422.98 | $396.99 | $423.78 | +679.83% |
| October, 2029 | $452.86 | $426.90 | $453.77 | +734.93% |
| November, 2029 | $483.34 | $455.77 | $483.64 | +791.12% |
| December, 2029 | $508.29 | $488.57 | $509.68 | +837.12% |
Moonlake Immunotherapeutics Stock (MLTX) Price Forecast for 2030
Moonlake Immunotherapeutics Stock (MLTX) is expected to reach an average price of $681.41 in 2030, with a high forecast of $849.26 and a low forecast of $513.56. This signifies an +1,156% surge from the last price of $54.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $562.90 | $513.56 | $567.45 | +937.79% |
| February, 2030 | $597.81 | $566.53 | $599.95 | +1,002% |
| March, 2030 | $618.83 | $602.72 | $620.07 | +1,041% |
| April, 2030 | $636.99 | $622.38 | $640.30 | +1,074% |
| May, 2030 | $671.33 | $642.81 | $677.84 | +1,138% |
| June, 2030 | $692.59 | $677.59 | $694.89 | +1,177% |
| July, 2030 | $718.22 | $682.58 | $719.90 | +1,224% |
| August, 2030 | $757.17 | $723.29 | $760.55 | +1,296% |
| September, 2030 | $778.61 | $757.16 | $779.80 | +1,335% |
| October, 2030 | $804.29 | $782.97 | $811.59 | +1,383% |
| November, 2030 | $824.14 | $805.48 | $826.19 | +1,419% |
| December, 2030 | $845.45 | $830.30 | $849.26 | +1,459% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):